NRC expected to issue Mo-99 facility license for Shine in 2021

May 13, 2020, 9:10PMNuclear News

Shine Medical Technologies, which is building a medical isotope production facility in Janesville, Wis., said on May 11 that it expects to have an operating license issued by the Nuclear Regulatory Commission by October 2021. Shine’s application seeking approval to operate the facility, which will produce isotopes including molybdenum-99, was accepted and docketed by the NRC last October. Mo-99, the precursor to technetium-99m, is used in more than 40 million medical patient procedures every year.

To continue reading, log in or create a free account!

Related Articles

Nuclear EOs: One year later

May 22, 2026, 12:46PMNuclear News

This Saturday, May 23, will mark one year since President Trump issued four executive orders (EOs) that sought to implement sweeping changes across the U.S. nuclear industry. From regulatory...

Dow gets EA/FONSI for Seadrift project

May 20, 2026, 7:18AMNuclear News

At the end of April, TerraPower announced that it had officially begun construction on its Natrium power plant in Kemmerer, Wyo.—one of the two full-scale demonstration projects in the...